Cmpx stock forecast.

The average Cabaletta Bio stock price prediction forecasts a potential upside of 75.22% from the current CABA share price of $18.67. What is CABA's forecast return on equity (ROE) for 2023-2026? (NASDAQ: CABA) forecast ROE is N/A, which is considered weak.Compass Therapeutics (NASDAQ: CMPX) is owned by 70.34% institutional shareholders, 11.41% Compass Therapeutics insiders, and 18.26% retail investors. Thomas J. Schuetz is the largest individual Compass Therapeutics shareholder, owning 5.98M shares representing 4.69% of the company.In this article, we answer “what is sales forecasting?” by breaking down its objectives, owners, methods, and best practices. Sales | What is REVIEWED BY: Jess Pingrey Jess served on the founding team of a successful B2B startup and has use...After a massive correction of 61% YTD, CMPX stock looks deeply undervalued and is poised for a strong reversal rally. As an overview, Compass is a clinical-stage oncology-focused company that’s ...

The consensus price target of analysts on Wall Street is $9.17, which implies an increase of 82.01% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $8.00 and $11.00 respectively. As a result, CMPX is trading at a discount of -566.67% off the target high and -384.85% off the low.Our goal is to do fundamental research, invent new technology, and create frameworks for stock forecast.

Their COEP share price targets range from $3.00 to $6.00. On average, they expect the company's stock price to reach $4.33 in the next twelve months. This suggests a possible upside of 270.4% from the stock's current price. View analysts price targets for COEP or view top-rated stocks among Wall Street analysts.

1.57%. $249.05M. CIX | Complete CompX International Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.NSD:CMPX Detailed Stock Analysis, Stock Price Forecasts, Analyst Ratings, Financial Analysis, Stock News & Historic Quotes Track Compass Therapeutics Inc (CMPX) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsThe development of new drugs generally has a high failure rate, and such failures may negatively impact the stock price of the company developing the failed ...

According to the issued ratings of 4 analysts in the last year, the consensus rating for Catalyst Pharmaceuticals stock is Buy based on the current 4 buy ratings for CPRX. The average twelve-month price prediction for Catalyst Pharmaceuticals is $24.75 with a high price target of $27.00 and a low price target of $24.00.

Compass Therapeutics (CMPX) Stock Forecast & Price Target $1.72 0.00 (0.00%) (As of 01:47 PM ET) Compare Today's Range $1.68 $1.72 50-Day Range $1.40 $2.13 52-Week …

Nowadays finding high-quality stock photos for personal or commercial use is very simple. You just need to search the photo using a few descriptive words and let Google do the rest of the work.Predicting the weather has long been one of life’s great mysteries — at least for regular folks. Over the years, you’ve probably encountered a few older adults — maybe even your own grandparents — who made some weather predictions based on ...Based on analysts offering 12 month price targets for CMPX in the last 3 months. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00 .Get free stock tools, free stock ratings, free stock charts and calculate the value of stocks to buyWhat this means: InvestorsObserver gives Compass Therapeutics Inc. (CMPX) an overall rank of 34, which is below average. Compass Therapeutics Inc. is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. A rank of 34 means that 66% of stocks appear more favorable to our system.

Analyst Future Growth Forecasts. Earnings vs Savings Rate: CMPX is forecast to remain unprofitable over the next 3 years. Earnings vs Market: CMPX is …With stocks at historic highs, many individuals are wondering if the time is right to make their first foray in the stock market. The truth is, there is a high number of great stocks to buy today. However, you might be unsure how to begin.Website. 2014. 26. Tom Schuetz. https://www.compasstherapeutics.com. Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases. The company’s product candidates include CTX-009, a bispecific antibody that blocks Delta-like ligand 4 ...Stock Price Forecast. According to 4 stock analysts, the average 12-month stock price forecast for CMPX stock stock is $9.33, which predicts an increase …Find the latest Compass Therapeutics, Inc. CMPX analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports. Date Range investment rating

Apple Inc. Common Stock. $180.07 -0.12 -0.07%. Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs ...

People use statistics daily for weather forecasts, predicting disease, preparing for emergencies, medical research, political campaigns, tracking sales, genetics, insurance, the stock market and quality testing.66.07%. Get the latest Compass Therapeutics Inc. (CMPX) real-time quote, historical performance, charts, and other financial information to help you make more informed …FCEL Stock 12 Months Forecast. Based on 6 Wall Street analysts offering 12 month price targets for Fuelcell Energy in the last 3 months. The average price target is $1.65 with a high forecast of $2.00 and a low forecast of $1.00. The average price target represents a 35.25% change from the last price of $1.22.Their COEP share price targets range from $3.00 to $6.00. On average, they expect the company's stock price to reach $4.33 in the next twelve months. This suggests a possible upside of 270.4% from the stock's current price. View analysts price targets for COEP or view top-rated stocks among Wall Street analysts.The development of new drugs generally has a high failure rate, and such failures may negatively impact the stock price of the company developing the failed ...CMPX Stock Predictions. CMPX Stock Buy or Sell? - Get a free CMPX stock trend analysis report to help you analyze and make a better CMPX stock predictions. The stock analysis service is provided by MarketClub, using their Smart Scan and Trade Triangle technology. It uses technical analysis and the current market condition to give you the best ... Compass Therapeutics (CMPX) Stock Forecast & Price Prediction. Estimation of the future price movement of Compass Therapeutics stock, based on various factors such as …

Oct 2, 2023 · Future criteria checks 0/6. Compass Therapeutics is forecast to grow earnings and revenue by 21.6% and 76.7% per annum respectively while EPS is expected to grow by 25.3% per annum.

May 31, 2022 · The stock has increased 17.9% in price over the past month and closed Friday’s trading session at $3.03. Each of the four Wall Street analysts that rated ELEV rated it Buy. The 12-month median price target of $11.50 indicates a 279.5% potential upside. The price targets range from a low of $11.00 to a high of $12.00.

Get the latest news and real-time alerts from Compass Therapeutics, Inc. (CMPX) stock at Seeking Alpha. ... CMPX Compass Therapeutics, Inc. Latest News. Follow $1.93 0.00 (0.00%) ...The CompX International stock forecast for tomorrow is $ 23.75, which would represent a -1.06% loss compared to the current price. In the next week, the price of CIX is expected to decrease by -9.90% and hit $ 21.62. As far as the long-term CompX International stock forecast is concerned, here ... Predictions of CMPX stock price for tomorrow.Based on analysts offering 12 month price targets for CMPX in the last 3 months. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00 .The average Albemarle stock price prediction forecasts a potential upside of 66.63% from the current ALB share price of $121.27. What is ALB's forecast return on equity (ROE) for 2023-2026? (NYSE: ALB) forecast ROE is N/A, which is considered weak.Nov 29, 2023 · CompX International Inc. (NYSE:CIX) posted its quarterly earnings data on Wednesday, November, 1st. The company reported $0.47 earnings per share for the quarter. The business earned $40.30 million during the quarter. CompX International had a net margin of 13.09% and a trailing twelve-month return on equity of 12.79%. The average price target for aTyr Pharma is $21.50. This is based on 4 Wall Streets Analysts 12-month price targets, issued in the past 3 months. The highest analyst price target is $35.00 ,the lowest forecast is $12.00. The average price target represents 1785.96% Increase from the current price of $1.14.US Stock MarketDetailed Quotes. PEPG PepGen. Close 11/13 16:00 ET. 4.340. +0.480 +12.44%. High 4.762 ... Inc. (PEPG), 4D Molecular Therapeutics (FDMT) and ...SOS Limited - ADR Stock Forecast, SOS stock price prediction. Price target in 14 days: 4.203 USD. The best long-term & short-term SOS Limited - ADR share price ...Compass Therapeutics, Inc. Common Stock (CMPX) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Compass Therapeutics (CMPX) Stock Forecast & Price Target $1.72 0.00 (0.00%) (As of 01:47 PM ET) Compare Today's Range $1.68 $1.72 50-Day Range $1.40 $2.13 52-Week …

The U.S. National Weather Service (NWS) is a part of the National Oceanic and Atmospheric Administration (NOAA). Many people rely on the National Weather Service’s forecasts in order to better anticipate what the weather will be like so the...Compass Therapeutics Inc. (CMPX) stock has fallen -6.02% while the S&P 500 is higher by 0.38% as of 3:09 PM on Thursday, May 18. CMPX has fallen -$0.19 from the previous closing price of $3.24 on volume of 185,132 shares. Over the past year the S&P 500 is up 6.40% while CMPX is higher by 23.48%. CMPX lost -$0.36 per share the over …Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools. Identify stocks that meet your criteria using seven unique stock screeners.Instagram:https://instagram. sell xbox 360 games for cashmoffittnetflying car company stockhalf dollar coins worth 4 brokers have issued twelve-month target prices for Catalyst Pharmaceuticals' stock. Their CPRX share price targets range from $24.00 to $27.00. On average, they predict the company's stock price to reach $24.75 in the next twelve months. This suggests a possible upside of 67.0% from the stock's current price.Compass Therapeutics (CMPX) Stock Forecast & Price Prediction. Estimation of the future price movement of Compass Therapeutics stock, based on various factors such as historical price trends, market trends, company performance, and economic conditions. btf stocklulu price 66.07%. Get the latest Compass Therapeutics Inc. (CMPX) real-time quote, historical performance, charts, and other financial information to help you make more informed …Our goal is to do fundamental research, invent new technology, and create frameworks for stock forecast. nasdaq tsll Back to CMPX Overview. *The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. It is possible that this date will be updated in the future, once ... Greenlane Holdings, Inc. (NASDAQ:GNLN) released its earnings results on Monday, November, 15th. The company reported ($46.00) earnings per share for the quarter, missing the consensus estimate of ($14.00) by $32.00. The company had revenue of $41.31 million for the quarter, compared to analyst estimates of $40.31 million.NSD:CMPX Detailed Stock Analysis, Stock Price Forecasts, Analyst Ratings, Financial Analysis, Stock News & Historic Quotes